Stand Up To Cancer

A new program from 23andMe called Research Revolution aims to empower people to drive the direction of genetic research. By enrolling in the Research Revolution, participants earn the right to vote on the lines of research to be pursued; because genetic research also requires control data, anyone can enroll to be a study participant, and will receive access to their own genetic data in return. Though the value of the program for cancer research has yet to be determined, the project's collaborative model for data collection and sharing shows great potential; in its personalized approach, the Research Revolution mirrors some of the most cutting-edge directions of today's cancer research.

23andMe has pledged to do research on any disease that enrolls enough patients to ensure a productive study. Three cancer subtypes are included in its initial round: lymphoma and leukemia, which will be studied together, and testicular cancer.

To learn more, visit https://www.23andme.com/researchrevolution/overview/.